MedKoo Cat#: 578135 | Name: Nivimedone sodium monohydrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Nivimedone sodium monohydrate inhibits mediator release and capillary permeability.

Chemical Structure

Nivimedone sodium monohydrate
CAS#62077-09-2

Theoretical Analysis

MedKoo Cat#: 578135

Name: Nivimedone sodium monohydrate

CAS#: 62077-09-2

Chemical Formula: C11H10NNaO5

Exact Mass: 259.0457

Molecular Weight: 259.19

Elemental Analysis: C, 50.97; H, 3.89; N, 5.40; Na, 8.87; O, 30.86

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Nivimedone sodium monohydrate; Nivimedone sodium hydrate
IUPAC/Chemical Name
sodium (5,6-dimethyl-1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)azinate hydrate
InChi Key
CCVFYFVABDKJST-UHFFFAOYSA-N
InChi Code
InChI=1S/C11H8NO4.Na.H2O/c1-5-3-7-8(4-6(5)2)11(14)9(10(7)13)12(15)16;;/h3-4H,1-2H3;;1H2/q-1;+1;
SMILES Code
O.[Na+].Cc1cc2C(=O)C(=N(=O)[O-])C(=O)c2cc1C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 259.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lumb EM, McHardy GJ, Kay AB. The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils. Br J Clin Pharmacol. 1979 Jul;8(1):65-74. doi: 10.1111/j.1365-2125.1979.tb05911.x. PMID: 121884; PMCID: PMC1429720. 2: Spicer BA, Ross JW, Sharpe TJ, Smith H. Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum. Int Arch Allergy Appl Immunol. 1978;56(6):493-9. doi: 10.1159/000232064. PMID: 415988. 3: Meadow SR, Sarsfield JK. Steroid-responsive and nephrotic syndrome and allergy: clinical studies. Arch Dis Child. 1981 Jul;56(7):509-16. doi: 10.1136/adc.56.7.509. PMID: 6791592; PMCID: PMC1627348. 4: Ross JW, Smith H, Spicer BA. Increased vascular permeability during passive peritoneal anaphylaxis in the rat. The effects of disodium cromoglycate and a nitroindanedione. Int Arch Allergy Appl Immunol. 1976;51(2):226-37. doi: 10.1159/000231595. PMID: 58838. 5: Sharpe TJ, Smith H. Effects of drugs on the acute inflammation following intraperitoneal injection of antigen into actively sensitised rats. Int Arch Allergy Appl Immunol. 1979;60(2):216-21. doi: 10.1159/000232344. PMID: 89095. 6: González R, Arruzazabala ML, Sarracent J. Effects of antiallergic drugs on cyclic nucleotides in guinea pig ileum and trachea. Allergol Immunopathol (Madr). 1987 Nov-Dec;15(6):361-3. PMID: 2833089. 7: Sharpe TJ, Ross JW, Spicer BA. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro. Agents Actions. 1978 Apr;8(3):199-202. doi: 10.1007/BF01966603. PMID: 78665. 8: Browne JT, Smyth WF. Polarographic behaviour and analysis of 2-nitro-5,6-dimethylindane-1,3-dione in raw materials and pharmaceutical formulations. Analyst. 1980 Jan;105(1246):25-9. doi: 10.1039/an9800500025. PMID: 7386887. 9: Pauwels R, Lamont H, Van der Straeten M. The inhibition of allergen induced bronchospasm in man by oral BRL 10833. Clin Allergy. 1976 Sep;6(5):471-8. doi: 10.1111/j.1365-2222.1976.tb01931.x. PMID: 824069. 10: Arruzazabala ML, Casacó A, González R, de la Vega AR. Efecto de varias drogas profilácticas antiasmáticas sobre la broncoconstricción inducida por keroseno en conejos [Effect of several antiasthmatic prophylactic drugs on bronchoconstriction induced by kerosene in rabbits]. Allergol Immunopathol (Madr). 1983 Nov-Dec;11(6):421-4. Spanish. PMID: 6422727.